Lv1
70 积分 2024-05-07 加入
Cross-validation of pharmacokinetic assays post-ICH M10 is not a pass/fail criterion
2天前
已完结
Current Considerations on Characterization of Immune Response to Multi-Domain Biotherapeutics
2天前
已完结
Reformation of a Clinical Anti-Drug Antibody Assay to Enable the Immunogenicity Assessment of a Bispecific Antibody Biotherapeutic
2天前
已完结
A novel approach to assess domain specificity of anti-drug antibodies to moxetumomab pasudotox, an immunotoxin with two functional domains
1个月前
已完结
Risk-Based Pharmacokinetic and Drug–Drug Interaction Characterization of Antibody–Drug Conjugates in Oncology Clinical Development: An International Consortium for Innovation and Quality in Pharmaceutical Development Perspective
4个月前
已完结
Validation of LC–MS/MS bioanalytical methods for protein therapeutics
4个月前
已完结
Validation of LC–MS/MS bioanalytical methods for protein therapeutics
4个月前
已关闭
LC–MS bioanalysis of intact proteins and peptides
4个月前
已完结
Decade-long leukaemia remissions with persistence of CD4+ CAR T cells
5个月前
已完结
Current and future concepts for the generation and application of genetically engineered CAR-T and TCR-T cells
6个月前
已完结
皖公网安备34019202002308
